Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-20 | $21.70 | $21.93 | +1.06% | 0.1M |
| 05-21 | $21.77 | $21.86 | +0.41% | 0.2M |
| 05-22 | $21.91 | $21.85 | -0.27% | 0.1M |
| 05-26 | $22.45 | $21.89 | -2.52% | 0.1M |
| 05-27 | $21.90 | $21.86 | -0.18% | 0.1M |
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $122.89M | $480.14M | $356.34M | $228.00M |
Operating Income | $9.54M | $24.74M | $19.42M | $10.45M |
Net Income | $5.12M | $19.52M | $15.41M | $10.08M |
EPS (Diluted) | $0.29 | $1.06 | $0.83 | $0.54 |
Total Assets | $261.46M | $261.15M | $264.81M | $254.88M |
Total Liabilities | $94.54M | $99.59M | $98.10M | $91.19M |
Cash & Equivalents | $87.58M | $93.89M | $95.55M | $81.34M |
Free Cash Flow OCF − CapEx | $-4.33M | $28.84M | $21.28M | $4.49M |
Shares Outstanding | 17.56M | 17.51M | 17.56M | 17.64M |
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.